Clinical Trial Update: Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 completed trial comparing edoxaban alone to edoxaban with an antiplatelet agent in patients with atrial fibrillation and chronic stable coronary artery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease
• Stable Angina

Drugs mentioned

• Antiplatelet agent
• Edoxaban (edoxaban)

Snippet

Sponsor: Gi-Byoung Nam | Conditions: Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Status: COMPLETED